The changes of the ovarian function after ectopic pregnancy treatment (laparoscopic salpingostomy and systemic methotrexate)

Öz

The Changes of The Ovarian Function after Ectopic Pregnancy Treatment (Laparoscopic salpingostomy and systemic Methotrexate) Aim: To evaluate the changes of the ovarian function inpatients with ectopic pregnancy treated by laparoscopic salpingostomy and systemic single dose methotreaxate. Materials and Methods: This study was included 28 patients with ectopic pregnancy treated by laparoscopic salpingostomy and 14 patients with ectopic pregnancy treated by 50 mg/m2 single dose methotrexate, from January 2005 to July 2007. All patients were evaluated by transvaginal sonography before treatment to determine both ovarian volumes, antral follicle counts and bloodflow characteristics. SPSS for Windows 13.0 was used for statistical analysis. Results: The mean age was 30.6±4.5 in patients treated by laparoscopy, whereas it was 30.07±3.6 in patients treated by methotrexate (p: 0,68). Gravidity and partity were 0,92±1,11 and 0,50 ± 0,63 in patients treated by laparoscopy, whereas they were 0,78 ±0,8 and 0,5 ±0,65 in patients treated by methotrexate respectively. Conclusion: Our results showed that both treatment modalities (laparoscopic salpingostomy and systemic methotreaxate) have no adverse effect on the ovarianfunction.

Anahtar Kelimeler

• -

Ektopik gebelik sonrası (laparoskopik salpingostomi ve sistemik methotrexate) ovarian fonksiyonlardaki değişim

Öz

Amaç: Laparoskopik salpingostomi ve sistemik tek doz Methotrexate uygulanan hastalarda ovarian fonksiyonlardaki değişimi incelemektir. Gereç ve Yöntem: Bu çalışma Ocak 2005-Temmuz 2007 tarihleri arasında, Ektopikgebelik tanısı ile laparoskopik salpingostomi uygulanan 28 hasta ve 50 mg/m2 tek doz Methotrexate uygulanan 14 hasta dayapılmıştır. Tüm hastalara tedavi öncesi her iki overe ait volüm, antral follikül sayısı ve akım paternlerini değerlendirmek için transvajinal ultrasonografi uygulandı. İstatistiksel analiz için, SPSS for Windows 13.0 paket programı kullanıldı. Bulgular: Laparoskopik salpingostomi uygulanan grupta ortalama yaş 30,6 (-/+ 4,5) iken, Methotrexate uygulanan grupta ise 30,07 (-/+ 3,6) idi (p: 0,68). Hastaların gravida ve pariteleri değerlendirildiğinde sırası ile laparoskopik salpingostomi uygulanan grupta 0,92 (-/+ 1,11), 0,50 (-/+ 0,63) iken; Methotrexate uygulanan grupta ise 0,78 (-/+ 0,8), 0,5 (-/+ 0,65) idi. Sonuç: Elde edilen veriler uygulanan tedavi modalitelerinin (laparoskopik salpingostomi ve sistemik Methotrexate kullanımı) ovarian fonksiyonlar üzerinde olumsuz etkilerinin olmadığını göstermektedir.

Anahtar Kelimeler

• -

Kaynakça

1. 1. Ego, A., Subtil, D., Cosson, M., Legoueff, F.O., Houfflin-Debarge, V.R., Querleu,D., Survival analysis of fertility after ectopic Pregnancy, Fertility and Sterility, 75 (3), 2001
2. 2. Grainger, D.A., Seifer, D.B., Laparoscopic management of ectopic pregnancy, Current Opinion Obstet Gynecol, 7, 277-282, 1995
3. 3. Buster, J.E., Carson, S.A., Ectopic pregnancy: new advances in diagnosis and treatment, Current Opinion Obstet Gynecol Scand., 73, 746 - 752, 1994
4. 4. Gleicher, N., Barad, D., Unexplained infertility: does it really exist?, Hum Reprod., 21, 1951-1955, 2006
5. 5. Keay, S.D., Liversedge, N.H., Mathur, R.S. and Jenkins, J.M.Assisted conception following poor ovarian response to gonadotrophin stimulation, Br J Obstet Gynecol., 104, 521-527, 1997
6. 6. Tarlatzis, B.C., Zepiridis, L., Grimbizis, G. and Bontis, J., Clinical management of low ovarian response to stimulation for IVF: a systematic review. Hum Reprod Update, 9, 61-76, 2003
7. 7. Lass, A., Ellenbogen, A., Croucher, C., Trew, G., Margara R., Becattini, C., Winston R.M.L.,Effect of salpingectomy on ovarian response to superovulation in an in vitrofertilization-embryo transfer program, Fertility and Sterility, 70 (6), 1035-1038, 1998
8. 8. Guerriero, S., Ajossa, S., Lai, M.P., Risalvato, A., Paoletti, A.M. and Melis, G.B., Clinical applications of colour Doppler energy imaging in the female reproductive tract and pregnancy, Hum Reprod Update, 5, 515-529, 1999

9. 9. Cooper, J.A., White, D.A., Matthay, R.A., Drug-induced pulmonary disease. Part 1: Cytotoxic drugs, Am Rev Respir Dis., 133, 321-340, 1986
10. 10. Orvieto, IVF cycle following MTX therapy, Fertil Steril, 2007. Article in pres
11. 11. Dar, P., Sachs, G.S., Strassburger, D., Bukovsky, I., Arielli, S., Ovarian function before and after salpinjectomy in artificial reproductive technology patients, Hum Reprod., 15 (1), 142-144, 2000
12. 12. Verhulst, G., Vandersteen, N., Van Steirteghem, A.C., Devroey, P., Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer program, Hum Reprod., 9(4), 624-628, 1994
13. 13. Strandell, A., Lindhard, A.,Waldenstrom, U., Thorburn, J., Prophylactic salpingectomy does not impair the ovarian response in IVF treatment, Hum Reprod., 16(6), 1135-1139, 2001
14. 14. Chan C.C.W. ,.Ng, E.H.Y., Li, C.F. and Ho, P.C., Impaired ovarian blood flow and reduced antral follicle count following laparoscopic salpingectomy for ectopic pregnancy, Human Reproduction., 18(10) 2175-2180, 2003
15. 15. KelekciS., Yilmaz, B., Yakut, Y, Yasar, L., Savan, K., Sonmez, S., Hormonal and ovarian stromal blood supply changes after laparoscopic tubal sterilization: a prospective controlled study, Contraception, 73, 279- 283, 2006
16. 16. Sumiala, S., Pirhonen, J., Tuominen, J. and Maenpaa, J., Increased uterine and ovarian vascular resistance following Filshie clip sterilization: preliminary findings obtained with color Doppler ultrasonography, J. Clin. Ultrasound, 23, 511-516, 1995
17. 17. Geber, S. and Caetano, J.P., Doppler colour flow analysis of uterine and ovarian arteries prior to and after surgery for tubal sterilization: a prospective study, Hum. Reprod., 11, 1195-1198, 1996